Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Spruce Biosciences Inc.

    NASDAQ: SPRB · Real-Time Price · USD
    0.06
    -0.00 (-0.99%)
    At close: Jun 06, 2025, 3:57 PM
    0.06
    -5.47%
    After-hours: Jun 06, 2025, 03:57 PM EDT

    Spruce Biosciences Statistics

    Share Statistics

    Spruce Biosciences has 42.23M shares outstanding. The number of shares has increased by 0.36% in one year.

    Shares Outstanding

    n/a
    		 42.23M

    Shares Change (YoY)

    n/a
    		 0.36%

    Shares Change (QoQ)

    n/a
    		 0%

    Owned by Institutions (%)

    n/a
    		 27.03%

    Shares Floating

    n/a
    		 n/a

    Failed to Deliver (FTD) Shares

    n/a
    		 39,498

    FTD / Avg. Volume

    n/a
    		 2.84%

    Short Selling Information

    The latest short interest is 18.06K, so 0.04% of the outstanding shares have been sold short.

    Short Interest

    n/a
    		 18.06K

    Short % of Shares Out

    n/a
    		 0.04%

    Short % of Float

    n/a
    		 0.04%

    Short Ratio (days to cover)

    n/a
    		 1

    Valuation Ratios

    The PE ratio is -0.33 and the forward PE ratio is -0.1. Spruce Biosciences's PEG ratio is -0.08.

    PE Ratio

    n/a
    		 -0.33

    Forward PE

    n/a
    		 -0.1

    PS Ratio

    n/a
    		 3.53

    Forward PS

    n/a
    		 0.1

    PB Ratio

    n/a
    		 0.6

    P/FCF Ratio

    n/a
    		 -0.31

    PEG Ratio

    n/a
    		 -0.08
    Financial Ratio History

    Enterprise Valuation

    Currently the Enterprise Value (EV) is not available for Spruce Biosciences.

    EV / Sales

    n/a
    		 n/a

    EV / EBITDA

    n/a
    		 n/a

    EV / EBIT

    n/a
    		 n/a

    EV / FCF

    n/a
    		 n/a

    Financial Position

    The company has a current ratio of 2.9, with a Debt / Equity ratio of 0.1.

    Current Ratio

    n/a
    		 2.9

    Quick Ratio

    n/a
    		 2.9

    Debt / Equity

    n/a
    		 0.1

    Debt / EBITDA

    n/a
    		 -0.05

    Debt / FCF

    n/a
    		 -0.05

    Interest Coverage

    n/a
    		 -182.9

    Financial Efficiency

    Return on Equity is n/a and Return on Invested Capital is n/a.

    Return on Equity

    n/a
    		 n/a

    Return on Assets

    n/a
    		 n/a

    Return on Invested Capital

    n/a
    		 n/a

    Revenue Per Employee

    n/a
    		 $245,550

    Profits Per Employee

    n/a
    		 $-2,651,800

    Employee Count

    n/a
    		 20

    Asset Turnover

    n/a
    		 0.11

    Inventory Turnover

    n/a
    		 n/a

    Taxes

    Income Tax

    n/a
    		 n/a

    Effective Tax Rate

    n/a
    		 0%

    Stock Price Statistics

    The stock price has increased by -91.1% in the last 52 weeks. The beta is 2.5, so Spruce Biosciences's price volatility has been higher than the market average.

    Beta

    n/a
    		 2.5

    52-Week Price Change

    n/a
    		 -91.1%

    50-Day Moving Average

    n/a
    		 0.14

    200-Day Moving Average

    n/a
    		 0.37

    Relative Strength Index (RSI)

    n/a
    		 28.53

    Average Volume (20 Days)

    n/a
    		 1,389,892

    Income Statement

    In the last 12 months, Spruce Biosciences had revenue of 4.91M and earned -53.04M in profits. Earnings per share was -1.29.

    Revenue

    n/a
    		 4.91M

    Gross Profit

    n/a
    		 4.91M

    Operating Income

    n/a
    		 -56.15M

    Net Income

    n/a
    		 -53.04M

    EBITDA

    n/a
    		 -56.15M

    EBIT

    n/a
    		 -52.73M

    Earnings Per Share (EPS)

    n/a
    		 -1.29
    Full Income Statement

    Balance Sheet

    The company has 38.75M in cash and 2.77M in debt, giving a net cash position of 35.99M.

    Cash & Cash Equivalents

    n/a
    		 38.75M

    Total Debt

    n/a
    		 2.77M

    Net Cash

    n/a
    		 35.99M

    Retained Earnings

    n/a
    		 -250.27M

    Total Assets

    n/a
    		 31.65M

    Working Capital

    n/a
    		 14.91M
    Full Balance Sheet

    Cash Flow

    In the last 12 months, operating cash flow was -55.96M and capital expenditures 0, giving a free cash flow of -55.96M.

    Operating Cash Flow

    n/a
    		 -55.96M

    Capital Expenditures

    n/a
    		 n/a

    Free Cash Flow

    n/a
    		 -55.96M

    FCF Per Share

    n/a
    		 -1.36
    Full Cash Flow Statement

    Margins

    Gross margin is 100%, with operating and profit margins of -1143.37% and -1079.94%.

    Gross Margin

    n/a
    		 100%

    Operating Margin

    n/a
    		 -1143.37%

    Pretax Margin

    n/a
    		 -1079.94%

    Profit Margin

    n/a
    		 -1079.94%

    EBITDA Margin

    n/a
    		 -1143.37%

    EBIT Margin

    n/a
    		 -1143.37%

    FCF Margin

    n/a
    		 -1139.56%

    Dividends & Yields

    SPRB does not appear to pay any dividends at this time.

    Dividend Per Share

    n/a
    		 n/a

    Dividend Yield

    n/a
    		 n/a

    Dividend Growth (YoY)

    n/a
    		 n/a

    Payout Ratio

    n/a
    		 n/a

    Earnings Yield

    n/a
    		 n/a

    FCF Yield

    n/a
    		 n/a
    Dividend Details

    Analyst Forecast

    The average price target for SPRB is $1.75, which is 2816.7% higher than the current price. The consensus rating is "Hold".

    Price Target

    n/a
    		 $1.75

    Price Target Difference

    n/a
    		 2816.7%

    Analyst Consensus

    n/a
    		 Hold

    Analyst Count

    n/a
    		 5
    Stock Forecasts

    Fair Value

    There are several formulas that can be used to estimate the intrinsic value of a stock.

    Lynch Fair Value

    n/a
    		 n/a

    Lynch Upside

    n/a
    		 n/a

    Graham Number

    n/a
    		 n/a

    Graham Upside

    n/a
    		 n/a

    Scores

    Altman Z-Score

    n/a
    		 -16.74

    Piotroski F-Score

    n/a
    		 1

    Add to Watchlist